SHPH
NASDAQ
US
Shuttle Pharmaceuticals Holdings, Inc. - common stock
$0.76
▲ +$0.09
(+12.78%)
Vol 209K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$2.9M
ROE
-476.1%
D/E
29.95
Beta
0.53
52W
$1–$25
Price Chart
Similar Stocks
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -329.9% | -329.9% | -329.9% | -329.9% | -329.9% | -476.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 12.37 | 12.37 | 12.37 | 12.37 | 12.37 | 29.95 |
| Current Ratio | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 1.66 |
Key Ratios
ROA (TTM)
-253.9%
P/B
4.4
EPS (TTM)
$-26.48
CF/Share
$-0.36
52W High
$25.25
52W Low
$1.26
$1.26
52-Week Range
$25.25
How does SHPH compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
SHPH valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
4.4
▲
80%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
SHPH profitability vs Biotechnology peers
ROE
-476.1%
▼
607%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-253.9%
▼
444%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
SHPH financial health vs Biotechnology peers
D/E ratio
30.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
1.7
▼
63%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.5
▼
45%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
SHPH fundamentals radar
SHPH
Peer median
Industry
SHPH profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
SHPH vs peers: key metrics
Latest News
No related news yet